Current Pharmaceutical Biotechnology

2.7k papers and 54.4k indexed citations i.

About

The 2.7k papers published in Current Pharmaceutical Biotechnology in the last decades have received a total of 54.4k indexed citations. Papers published in Current Pharmaceutical Biotechnology usually cover Molecular Biology (1.1k papers), Oncology (207 papers) and Pharmacology (184 papers) specifically the topics of RNA Interference and Gene Delivery (146 papers), Monoclonal and Polyclonal Antibodies Research (123 papers) and Nanoparticle-Based Drug Delivery (100 papers). The most active scholars publishing in Current Pharmaceutical Biotechnology are Undurti N. Das, Prashant Bisen, John S. Philo, David M. Dohan Ehrenfest, Tsutomu Arakawa, Hans‐Georg Sahl, Gabriele Bierbaum, Janice M. Reichert, William C. Campbell and Stephen T. Abedon.

In The Last Decade

Fields of papers published in Current Pharmaceutical Biotechnology

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in Current Pharmaceutical Biotechnology. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Current Pharmaceutical Biotechnology.

Countries where authors publish in Current Pharmaceutical Biotechnology

Since Specialization
Citations

This map shows the geographic impact of research published in Current Pharmaceutical Biotechnology. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Current Pharmaceutical Biotechnology with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Current Pharmaceutical Biotechnology more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore journals with similar magnitude of impact

Rankless by CCL
2025